a pituuskasvun hidastuminen oli 9%) ja painon kehityksen hidastuminen (painon kehitys hidastui ###>In general, the adverse event profile in the limited paediatric population studied was similar to that observed in adults, although there is a paediatric specific concern regarding growth inhibition as decrease in height (mean percentile decrease of growth velocity of 9%) and weight (mean percentile decrease of 13%)